SPEAKER INDEX CONTENTS INSERTS
ALLISON K. KIERNAN 3
BIRX 31 41 42 44
BURR 22 23 24 41 42 43 44 46 48
50 51 52 53 54 59 65 71 72
73 75 76 77 78
CAPPS 27 28 29
DAULAIRE 55 66 67 70 73 76 78
DE LAY 33 42 43 44 51 52 53
FAUCI 12 14 15 16 17 18 19 20 21
22 23 24 25 26 27 28 29 30
GEJDENSON 7 21 22 46 47 48
GILMAN 5 8 9 10 12 14 15 16 19
21 22 24 27 29 30 33 35 38
40 48 51 62
HAMILTON 7 16 17 18 19 44 45 46
LANTOS 8
MARK S. KIRK 3
MCDERMOTT 48 49 65 66 67 68 69 71
MERSON 62 67 68 70 71 73 74 75 77
MICHAEL H. VAN DUSEN 3
PAYNE 24 25 26 27
PELOSI 39 48 50 51
PIOT 36 45 46 47 48 49 50 51 52
53
PORTER 10 19 20 21
RICHARD J. GARON 3
SHERMAN 51
YOUNG 59 71 72 75 77
CONTENTS SPEAKERS INSERTS
STATEMENT OF DR. ANTHONY FAUCI, DIRECTOR, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
PAGE 11
STATEMENT OF COLONEL DEBORAH BIRX, M.D., DIRECTOR, U.S. MILITARY HIV RESEARCH PROGRAM
PAGE 31
STATEMENT OF DR. PAUL DE LAY, CHIEF OF HIV/AIDS DIVISION, U.S. AGENCY FOR INTERNATIONAL DEVELOPMENT
PAGE 33
STATEMENT OF DR. PETER PIOT, EXECUTIVE DIRECTOR, UNAIDS
PAGE 36
STATEMENT OF DR. NILS DAULAIRE, PRESIDENT, NATIONAL COUNCIL FOR INTERNATIONAL HEALTH
PAGE 54
STATEMENT OF PETER YOUNG, VICE PRESIDENT OF HIV AND OPPORTUNISTIC INFECTIONS RESEARCH AND
DEVELOPMENT, GLAXO WELLCOME, INC.
PAGE 59
STATEMENT OF MICHAEL H. MERSON, M.D., DEAN OF PUBLIC HEALTH, YALE UNIVERSITY SCHOOL OF MEDICINE
PAGE 62
INSERTS SPEAKERS CONTENTS
NO INSERTS IN THIS HEARING